Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)

Name: Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
Published: 2016
License: Public Domain

University Hospital, Bordeaux · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

aortic valve stenosis, tavi, antiplatelet agent, ticagrelor, cerebrovascular events, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)

Related documents